Long-term follow-up of first generation versus new-generation drug-eluting stents in three-vessel coronary artery disease

Authors/Task Force members, 2014, Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu278 Serruys, 2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056/NEJMoa0804626 Stone, 2010, Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease, N Engl J Med, 362, 1663, 10.1056/NEJMoa0910496 Nashef, 1999, European system for cardiac operative risk evaluation (EuroSCORE), Eur J Cardiothorac Surg, 16, 9, 10.1016/S1010-7940(99)00134-7 Kim, 2006, EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting, Am J Cardiol, 98, 1567, 10.1016/j.amjcard.2006.07.031 Romagnoli, 2009, EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention, Heart, 95, 43, 10.1136/hrt.2007.134114 Laskey, 2007, Thrombosis in coronary drug-eluting stents: report from the meeting of the circulatory system medical devices advisory panel of the Food and Drug Administration Center for devices and radiologic health, December 7–8, 2006, Circulation, 115, 2352, 10.1161/CIRCULATIONAHA.107.688416 Sianos, 2005, The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention, 1, 219 Perlman, 2005, Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the renal research institute-CKD study, Am J Kidney Dis, 45, 658, 10.1053/j.ajkd.2004.12.021 Jensen, 2016, Safety and efficacy of everolimus- versus sirolimus-eluting stents: 5-year results from SORT OUT IV, J Am Coll Cardiol, 67, 751, 10.1016/j.jacc.2015.11.051 Gada, 2013, JACC Cardiovasc Interv, 6, 1263, 10.1016/j.jcin.2013.07.009 Haiek, 2016, Second vs. first generation drug eluting stents in multiple vessel disease and left main stenosis: two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry, Catheter Cardiovasc Interv Maeng, 2014, Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial, Lancet, 383, 2047, 10.1016/S0140-6736(14)60405-0 Kappetein, 2011, Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial, Eur Heart J, 32, 2125, 10.1093/eurheartj/ehr213 Best, 2002, The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions, J Am Coll Cardiol, 39, 1113, 10.1016/S0735-1097(02)01745-X Takagi, 2014, Impact of renal dysfunction on long-term mortality in patients with unprotected left main disease: Milan and new-Tokyo (MITO) registry, Int J Cardiol, 177, 1131, 10.1016/j.ijcard.2014.08.048 Tonino, 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, N Engl J Med, 360, 213, 10.1056/NEJMoa0807611